News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
546,106 Results
Type
Article (13667)
Company Profile (158)
Press Release (532358)
Multimedia
Podcasts (10)
Webinars (9)
Section
Business (179411)
Career Advice (570)
Deals (27407)
Drug Delivery (41)
Drug Development (61576)
Employer Resources (44)
FDA (11956)
Job Trends (9872)
News (263269)
Policy (21779)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (2)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (999)
Accelerated approval (43)
ADA (30)
Adcomms (15)
Allergies (124)
Alliances (37164)
ALS (132)
Alzheimer's disease (1159)
Antibody-drug conjugate (ADC) (383)
Approvals (12607)
Artificial intelligence (501)
ASCO (235)
Autoimmune disease (258)
Automation (53)
Bankruptcy (275)
Belgium (2)
Best Places to Work (8179)
BIO (47)
Biologics (11)
BIOSECURE Act (2)
Biosimilars (144)
BioSpace Insights (56)
Biotechnology (95)
Bispecific (1)
Bladder cancer (196)
Brain cancer (64)
Breast cancer (705)
Cancer (5118)
Cardiovascular disease (333)
Career advice (475)
Career pathing (6)
CAR-T (247)
CDC (14)
CDMO (35)
Celiac Disease (2)
Cell therapy (665)
Cervical cancer (42)
Clinical research (56119)
Collaboration (1593)
Commercialization (6)
Company closure (1)
Compensation (1533)
Complete response letters (44)
COVID-19 (1179)
CRISPR (84)
C-suite (923)
Cystic fibrosis (102)
Data (7268)
Denatured (8)
Depression (124)
Dermatology (83)
Diabetes (455)
Diagnostics (5322)
Digital health (52)
Diversity (4)
Diversity, equity & inclusion (14)
Drug discovery (215)
Drug pricing (27)
Drug shortages (4)
Duchenne muscular dystrophy (222)
Earnings (77824)
Editorial (17)
Employer branding (5)
Employer resources (45)
Events (95474)
Executive appointments (820)
FDA (15363)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (25)
Funding (1200)
Gene editing (163)
Generative AI (28)
Gene therapy (447)
GLP-1 (468)
Government (1635)
Grass and pollen (2)
Guidances (342)
Healthcare (11962)
Hematology (145)
HIV (67)
Huntington's disease (30)
IgA nephropathy (87)
Immunology and inflammation (141)
Immuno-oncology (87)
Indications (186)
Infectious disease (1429)
Inflammatory bowel disease (147)
Inflation Reduction Act (5)
Influenza (107)
Intellectual property (279)
Interviews (91)
IPO (13125)
IRA (4)
Job creations (2104)
Job search strategy (406)
JPM (15)
Kidney cancer (20)
Labor market (5)
Layoffs (95)
Leadership (9)
Legal (5626)
Licensing (18)
Liver cancer (79)
Longevity (24)
Lung cancer (695)
Lymphoma (379)
Machine learning (42)
Management (17)
Manufacturing (797)
Marketing (12)
MASH (138)
Medical affairs (2)
Medical device (10525)
Medtech (10718)
Mergers & acquisitions (15446)
Metabolic disorders (949)
mRNA (94)
Multiple sclerosis (129)
Multispecific (1)
NASH (9)
Neurodegenerative disease (282)
Neuropsychiatric disorders (62)
Neuroscience (2243)
NextGen: Class of 2026 (3825)
Non-profit (1546)
Now hiring (2)
Obesity (323)
Opinion (104)
Ovarian cancer (194)
Pain (211)
Pancreatic cancer (296)
Parkinson's disease (249)
Partnered (27)
Patents (538)
Patient recruitment (666)
Patient selection (1)
Peanut (40)
People (44305)
Peptides (3)
Pharmaceutical (40)
Pharmacy benefit managers (12)
Phase 1 (17556)
Phase 2 (24884)
Phase 3 (17881)
Pipeline (9249)
Policy (71)
Postmarket research (1871)
Preclinical (7201)
Press Release (40)
Prostate cancer (264)
Psychedelics (27)
Radiopharmaceuticals (259)
Rare diseases (769)
Real estate (3539)
Recruiting (19)
Regulatory (18812)
Reports (28)
Research institute (1075)
Resumes & cover letters (91)
Rett syndrome (42)
RNA editing (7)
RSV (54)
Schizophrenia (131)
Series A (201)
Series B (146)
Service/supplier (6)
Sickle cell disease (73)
Special edition (1)
Spinal muscular atrophy (106)
Sponsored (25)
Startups (2240)
State (2)
Stomach cancer (7)
Supply chain (71)
Tariffs (6)
The Weekly (2)
Vaccines (516)
Venture capital (35)
Weight loss (141)
Women's health (104)
Worklife (2)
Date
Today (85)
Last 7 days (494)
Last 30 days (1602)
Last 365 days (22815)
2026 (16070)
2025 (22655)
2024 (26670)
2023 (30439)
2022 (38637)
2021 (41406)
2020 (38293)
2019 (28845)
2018 (21657)
2017 (21898)
2016 (20912)
2015 (27227)
2014 (23644)
2013 (19844)
2012 (21996)
2011 (22331)
2010 (21857)
Location
Africa (326)
Alabama (87)
Alaska (5)
Arizona (344)
Arkansas (11)
Asia (23353)
Australia (3221)
California (13322)
Canada (3516)
China (886)
Colorado (553)
Connecticut (492)
Delaware (332)
Europe (40895)
Florida (1995)
Georgia (417)
Hawaii (3)
Idaho (51)
Illinois (878)
India (71)
Indiana (418)
Iowa (21)
Japan (495)
Kansas (113)
Kentucky (34)
Louisiana (39)
Maine (38)
Maryland (1434)
Massachusetts (8842)
Michigan (330)
Minnesota (661)
Mississippi (4)
Missouri (105)
Montana (23)
Nebraska (16)
Nevada (127)
New Hampshire (74)
New Jersey (3182)
New Mexico (24)
New York (3196)
North Carolina (1510)
North Dakota (6)
Northern California (6713)
Ohio (339)
Oklahoma (20)
Oregon (25)
Pennsylvania (2502)
Puerto Rico (23)
Rhode Island (34)
South America (537)
South Carolina (79)
South Dakota (1)
Southern California (5496)
Tennessee (163)
Texas (2138)
United States (44305)
Utah (396)
Vermont (2)
Virginia (228)
Washington D.C. (48)
Washington State (1023)
West Virginia (1)
Wisconsin (104)
Wyoming (3)
546,106 Results for "standard bariatrics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Metabolic disorders
Amylyx eyes FDA filing for GLP-1 blocker after late-stage win in post-bariatric hypoglycemia
With a Phase 3 trial showing a reduction of serious and severe hypoglycemic episodes in patients who have undergone weight loss surgery, Amylyx Pharmaceuticals plans to file for approval this year. If granted market entry, avexitide could hit peak sales of $1.7 billion worldwide, analysts estimate.
August 18, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia
August 18, 2026
·
10 min read
Weight loss
Lilly’s triple agonist shows bariatric surgery–like weight loss results
Lilly met analysts’ sky-high expectations with 28.3% weight loss over 80 weeks for the triple hormone receptor agonist retatrutide in a highly anticipated readout on Thursday.
May 21, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Amylyx Pharmaceuticals to Announce Topline Results from its Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia on August 18, 2026
August 18, 2026
·
1 min read
Press Releases
Confo Therapeutics Announces Encouraging Preclinical Data for Post-bariatric Hypoglycemia Candidate CFTX-2034 at ENDO 2026
June 15, 2026
·
3 min read
Press Releases
Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia
May 5, 2026
·
7 min read
Press Releases
Standard BioTools Reports Second Quarter 2026 Financial Results
August 5, 2026
·
16 min read
Press Releases
Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026
·
1 min read
Press Releases
Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction
July 20, 2026
·
12 min read
Press Releases
Standard BioTools and Treeline Biosciences Announce Merger Agreement
June 8, 2026
·
17 min read
1 of 54,611
Next
